Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation

QR Code

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation

A retrospective study included 93 patients who underwent a drug conversion of the heart rhythm with amiodarone. They were divided into comparison groups. The first group consisted of 58 patients who received monotherapy with amiodarone. The second group consisted of 35 patients in whom propranololol...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. G. Pronin, A. V. Prokopenko
Format:	Article
Language:	Russian
Published:	Private institution educational organization of higher education "Medical University "ReaViz" 2020-12-01
Series:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:	cardiac rhythm medication conversion amiodarone propranolol arrhythmia atrial fibrillation
Online Access:	https://vestnik.reaviz.ru/jour/article/view/80
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
by: O. V. Gaisenok
Published: (2016-01-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01)

Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita
by: S. N. Bel'diev
Published: (2016-03-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
by: O. N. Miller, et al.
Published: (2010-08-01)

CLINICAL AND STATISTICAL EVALUATION OF THE CALLS OF PATIENTS WITH ATRIAL FIBRILLATION
by: N. F. Plavunov, et al.
Published: (2018-10-01)

Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem
by: Yu. M. Pozdnyakov, et al.
Published: (1970-01-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
by: M. Yu. Gilyarov, et al.
Published: (2010-12-01)

Atrial fibrillation and flutter – the unsolved problem of medicine
by: A. G. Pronin, et al.
Published: (2024-09-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals
by: N. Varma, et al.
Published: (2021-04-01)

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)

Association of iron deficiency with atrial fibrillation recurrence after pharmacological cardioversion
by: M. Kh. Valeev, et al.
Published: (2023-07-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Incidence and prognostic significance of atrial fibrillation in patients with tako-tsubo syndrome-systematic review and meta-analysis.
by: Andrzej Osiecki, et al.
Published: (2025-06-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)

EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER)
by: T. A. Istomina, et al.
Published: (2016-01-01)

Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study
by: Seokmoon Han, et al.
Published: (2025-07-01)

The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

A POSSIBILITY TO USE ANTIARRHYTHMIC MEDICATIONS FROM II CLASS AND MODULATED KINESITHERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN METABOLIC SYNDROME PATIENTS
by: A. I. Olesin, et al.
Published: (2015-11-01)

Amiodarone-Induced Hypothyroidism
by: Svetlana A. Chepurnenko, et al.
Published: (2019-12-01)

Impact of anxiety and depression disorders on adherence to anticoagulant therapy among patients with atrial fibrillation
by: R. S. Bogdanova, et al.
Published: (2022-08-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2021-11-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)

Accuracy and interpretability of smartwatch electrocardiogram for early detection of atrial fibrillation: A systematic review and meta‐analysis
by: Dr. Muhammad Iqhrammullah, et al.
Published: (2025-06-01)

Clinical and pathogenetic characteristics and management of patients with atrial fibrillation in a cardiology department at the present time
by: V. K. Kurashin, et al.
Published: (2020-07-01)

Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation
by: E. P. Popova, et al.
Published: (2020-11-01)

Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment
by: Yu. A. Bunin, et al.
Published: (2018-09-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
by: S. G. Kanorsky, et al.
Published: (2017-08-01)

Amiodarone in cardiac transplant waiting list patients with severe heart failure
by: N. N. Koloskova, et al.
Published: (2017-06-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2021-05-01)

PSYCHOSOMATIC CONNECTION IN ATRIAL FIBRILLATION
by: F. I. Belyalov
Published: (2014-07-01)

Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation
by: L. I. Folomeeva, et al.
Published: (2020-09-01)

CORRELATION BETWEEN HEART RHYTHM AND SYMPTOMS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AFTER CATHETER ABLATION AND ANTIARRHYTHMIC THERAPY BASED ON DATA OBTAINED FROM IMPLANTABLE CARDIAC MONITORS
by: A. A. Simonyan, et al.
Published: (2016-09-01)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01)